PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.63K Hold
100
﹤0.01% 456
2026
Q1
$5.41K Hold
100
﹤0.01% 428
2025
Q4
$5.6K Buy
+100
New +$5.18K ﹤0.01% 437

Other funds holding XPH

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s XPH Position: Q2 2026 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q2 2026 at 100 shares worth $6.63K. The position accounts for ﹤0.01% of the portfolio, ranked #456.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in XPH in Q4 2025 and has held it in 3 quarters since. 40 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. held 100 shares of State Street SPDR S&P Pharmaceuticals ETF worth $6.63K as of Q2 2026.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s portfolio in Q2 2026, its #456 holding.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2025 and has held it in 3 quarters since.
  • 40 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q2 2026, filed 7 Aug 2026.